Loading...
Loading...
Indian pharmaceutical companies like Glenmark and Zydus are introducing low-cost generic versions of GLP-1 drugs such as Ozempic and Wegovy. These generic versions are expected to cost as little as $14, making the medications much more affordable. The development could significantly expand access to these treatments in India and potentially other markets.
Extract how different sources frame this story. The analysis clusters headlines by editorial stance and identifies opposing perspectives.
Sign in to extract & analyse